Ms Jolien Neefs
Academic Medical Centre, Amsterdam (Netherlands (The))
Member of:
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
Thoracoscopic AF ablation is a successful treatment for patients with a giant left atrium
Event: ESC Congress 2019
Topic: Rhythm Control, Atrial Fibrillation Surgery
Session: Surgical therapy in arrhythmia
Sinus node dysfunction after thoracoscopic surgical ablation for atrial fibrillation
Event: EHRA 2019
Topic: Rhythm Control, Atrial Fibrillation Surgery
Session: Young EP poster session - Young meets Experienced
Should every patient with atrial fibrillation and CHA2DS2-VASc score of 1 be anticoagulated? A systemic review
Event: ESC Congress 2018
Topic: Stroke in Atrial Fibrillation
Session: Atrial fibrillation - epidemiology
Risk of atrial fibrillation in heart failure with preserved ejection fraction: results from the treatment of cardiac function with an aldosterone antagonist (TOPCAT) Study
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Atrial fibrillation obesity
Body fat distribution as risk factor of new-onset atrial fibrillation in The European Prospective Investigation Into Cancer and Nutrition in Norfolk Study
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Clinical and epidemiological aspects (Atrial Fibrillation)
Session: Rapid Fire session 8 - Atrial fibrillation and stroke prevention
Mineralocorticoid receptor antagonists as prevention in atrial fibrillation: a systematic review and meta-analysis
Event: ESC Congress 2016
Topic: Atrial fibrillation (AF)
Session: Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation
ESC 365 is supported by
